1241093-84-4

Basic information

• Product Name: (1S, 2S)-2-(4-Carbamoyl-phenyl)-cyclopropanecarboxylic acid
• Synonyms: (1S, 2S)-2-(4-Carbamoyl-phenyl)-cyclopropanecarboxylic acid
• CAS NO: 1241093-84-4
• Molecular Weight: 205.213
• Mol File: 1241093-84-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (1S, 2S)-2-(4-Carbamoyl-phenyl)-cyclopropanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (1S, 2S)-2-(4-Carbamoyl-phenyl)-cyclopropanecarboxylic acid(1241093-84-4)
• EPA Substance Registry System: (1S, 2S)-2-(4-Carbamoyl-phenyl)-cyclopropanecarboxylic acid(1241093-84-4)

Safety Data

• Hazardous Substances Data: 1241093-84-4(Hazardous Substances Data)

Upstream product

• 1240914-90-2 (1S,2S)-2-(4-cyano-phenyl)-cyclopropanecarboxylic acid 
• 6142-65-0 trans-(1S,2S)/(1R,2R)-2-(4-bromophenyl)cyclopropanecarboxylic acid 
• 1123620-89-2 (1S,2S)-2-(4-bromophenyl)cyclopropanecarboxylic acid 
• 1332345-01-3 C₁₀H₉BrO₂*C₁₂H₁₃N 
• 1240914-92-4 C₁₁H₁₀NO₃^(1-)*Na⁽¹⁺⁾ 
• 1029431-48-8 (R)-1-(4-bromophenyl)-2-chloroethanol 
• 875479-34-8 ethyl trans-2-(4-bromophenyl)cyclopropane-1-carboxylate 
• 62566-68-1 (R)-2-(4-bromophenyl)oxirane 
• 4209-02-3 1-(4-bromophenyl)-2-chloroethan-1-one 

Downstream Products

• 1240914-03-7 4-{(1S, 2S)-2-[((R)-4-cyclobutyl-2-methylpiperazin-1-yl)carbonyl]-cyclopropyl}-benzamide 
• 1119807-02-1 AZD₅₂₁₃ 

Relevant articles and documents

Crystalline Form Of A Cyclopropyl Benzamide Derivative

The present invention relates to a crystalline form of compound (I), 4-{(1S,2S)-2-[(4-cyclobutylpiperazin-1-yl)carbonyl]-cyclopropyl}-benzamide, pharmaceutical formulations containing said compound and to the use of said active compound in therapy.

Cyclopropyl Amide Derivatives

Disclosed herein is at least one cyclopropyl amide derivative, at least one pharmaceutical composition comprising at least one cyclopropyl amide derivative disclosed herein, and at least one method of using at least one cyclopropyl amide derivative disclosed herein for treating at least one histamine H3 receptor associated condition therewith.